Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lung Neoplasms 4Leukemia, Myeloid, Acute 4Meningeal Carcinomatosis 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Biphenotypic, Acute 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Glioma 2Glioblastoma 2Astrocytoma 2Uveal Melanoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Oligodendroglioma 1Nevus 1Meningeal Neoplasms 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Monocytic, Acute 1Leukemia, Hairy Cell 1Germinoma 1Down Syndrome 1Diabetes Insipidus 1

Interventions

Rituximab 26Cyclophosphamide 22Lenalidomide 21Prednisone 15Vincristine 13obinutuzumab 12Doxorubicin 12Magnetic Resonance Spectroscopy 10Bendamustine Hydrochloride 10Specimen Handling 8ibrutinib 7fludarabine 7Biopsy 7Peripheral Blood Stem Cell Transplantation 6pembrolizumab 5fludarabine phosphate 5Whole-Body Irradiation 5Radiotherapy 5zanubrutinib 4venetoclax 4tazemetostat 4R-CHOP protocol 4Prednisolone 4Mycophenolic Acid 3Etoposide 3Cyclosporine 3tisagenlecleucel 2polatuzumab vedotin 2orelabrutinib 2loncastuximab tesirine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Spinal Puncture × 90 days × Clear all
NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Mayo Clinic

Phase 1/2 Not yet recruiting
33 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡